Cognitive and Emotional Inoculation Against Nutrition-Related Misinformation in Young Adults

August 31, 2026 updated by: Beijing Normal University

Cognitive and Emotional Inoculation Against Nutrition-Related Misinformation in Young Adults: A Randomized Controlled Trial

This study aims to examine the effects of cognitive and emotional inoculation interventions on young adults' ability to identify and respond to nutrition-related misinformation on social media. The study will compare two game-based inoculation approaches-a cognitive inoculation intervention and an emotional inoculation intervention-with a control condition. Outcomes will be assessed at baseline, immediately after the intervention, and 2 weeks later.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Not yet recruiting

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Nutrition-related misinformation is increasingly disseminated through social media and may influence how young adults perceive and make decisions about food, diet, and health. Such misinformation may rely not only on inaccurate or unsupported claims but also on persuasive communication techniques, including appeals to authority, unrealistic promises, fear appeals, conspiracy narratives, and absolute or dichotomous framing. These techniques may influence judgments by eliciting trust, desire, anxiety, anger, or decision-related pressure.

This three-arm randomized controlled trial will compare two game-based inoculation interventions-a cognitive inoculation intervention and an emotional inoculation intervention-with a control condition. Participants will encounter common persuasive techniques used in nutrition-related misinformation and receive condition-specific feedback. The cognitive intervention is designed to promote recognition of misleading techniques and verification of supporting evidence. The emotional intervention is designed to promote recognition of emotional cues associated with manipulative messages and reflection on how such cues may influence judgment. The study will assess participants' responses to nutrition-related social media posts at baseline, immediately after the intervention, and 2 weeks later to examine both immediate and sustained effects.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
330

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Locations

  • China
    • Guangdong
      • Zhuhai, Guangdong, China, 519087
        • Beijing Normal University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Aged 18 to 30 years.
  2. Able to read and understand Chinese.
  3. Able to access and independently complete the online intervention game and study questionnaires.
  4. Has access to WeChat for study communication and follow-up reminders.
  5. Provides electronic informed consent.

Exclusion Criteria:

  1. Younger than 18 years or older than 30 years.
  2. Unable to read Chinese or independently complete the online study procedures.
  3. Does not provide electronic informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Cognitive Inoculation
Cognitive Game-Based Inoculation
Behavioral: Cognitive Game-Based Inoculation.
Participants will complete a five-level interactive game designed to build resistance to nutrition-related misinformation on social media. In each level, participants act as a health-content creator and choose between an original social media post and alternative titles that may use misleading persuasive techniques. The game addresses five techniques: fake authority, impossible expectations, fear appeals, conspiracy framing, and false dichotomies. After each decision, participants receive cognitive feedback explaining how the misleading technique operates, the linguistic cues that may indicate its use, and how to evaluate whether the claim is supported by verifiable evidence.
Experimental: Affective Inoculation
Emotional Game-Based Inoculation
Behavioral: Emotional Game-Based Inoculation.
Participants will complete a five-level interactive game designed to build resistance to nutrition-related misinformation on social media. The game uses the same scenarios and addresses the same five misleading techniques as the cognitive inoculation intervention: fake authority, impossible expectations, fear appeals, conspiracy framing, and false dichotomies. After each decision, participants receive emotional feedback designed to help them recognize and reflect on the emotional cues triggered by manipulative messages, including unwarranted reassurance, desire, anxiety, anger, and pressure to make extreme choices. The feedback explains how these emotional responses may influence judgment of nutrition-related information.
Active Comparator: General Nutrition Education
General Nutrition Health Education
Behavioral: General Nutrition Health Education.
Participants will read eight brief sections of general nutrition health education adapted from the Chinese Dietary Guidelines (2022). This condition provides credible healthy-diet information without instruction about nutrition-related misinformation, persuasive techniques, evidence verification, fact-checking, or emotional manipulation cues. The sections cover dietary variety; energy balance and physical activity; fruit and vegetable intake; animal-source foods; limiting salt, oil, sugar, and alcohol; regular meals and adequate hydration; food selection, label reading, and food hygiene; and sustainable dietary practices.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Perceived Credibility of Nutrition-Related Misinformation
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in perceived credibility of nutrition-related misinformation will be assessed using simulated social-media posts about diet and health. Participants will rate the extent to which they consider the information credible on a 7-point scale. Lower scores indicate lower perceived credibility of nutrition-related misinformation.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Manipulation-Technique Recognition Accuracy
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in the accuracy of recognizing manipulation techniques in nutrition-related social-media information will be assessed using simulated posts containing both misleading and accurate content. Participants will identify the persuasion or manipulation technique used in each post, or indicate that no misleading technique is present. Higher scores indicate better recognition accuracy.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Intention to Share Nutrition-Related Misinformation
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in willingness to share nutrition-related misinformation will be assessed using simulated social-media posts about diet and health. Participants will rate their willingness to share the information with others on a 7-point scale. Lower scores indicate lower intention to share nutrition-related misinformation.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Intention to Fact-Check Nutrition-Related Information
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in intention to verify nutrition-related information will be assessed using simulated social-media posts about diet and health. Participants will rate the extent to which they would check whether the information is accurate or supported by reliable evidence on a 7-point scale. Higher scores indicate greater intention to fact-check nutrition-related information.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Perceived Manipulativeness
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in perceived manipulativeness will be assessed by participants' ratings of the extent to which nutrition-related social-media posts are perceived as deliberately attempting to influence or guide their judgment. Ratings will be made on a 7-point scale. Higher scores indicate greater perceived manipulativeness.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Perceived Emotional Manipulation
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in perceived emotional manipulation will be assessed in response to nutrition-related social-media posts. Participants will rate the extent to which the posts rely on emotional appeals rather than factual information.Ratings will be made on 7-point scales.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Perceived Perceived Threat
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in perceived threat will be assessed in response to nutrition-related social-media posts. Participants will rate the extent to which the posts evoke concerns about personal health.Ratings will be made on 7-point scales.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Counterarguing in Response to Nutrition-Related Misinformation
Time Frame: Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Change from baseline in counterarguing will be assessed by participants' self-reported tendency to generate thoughts that question, challenge, or critically evaluate the claims made in nutrition-related social-media posts. Responses will be rated on a 7-point scale. Higher scores indicate greater counterarguing.
Baseline (T0), immediate post-intervention (T1), and 2-week follow-up (T2).
Misinformation-Detection Self-Efficacy
Time Frame: Baseline (T0) and 2-week follow-up (T2).
Change from baseline in confidence in detecting false, exaggerated, or insufficiently supported nutrition-related information and in verifying its source will be assessed using self-report items rated on 7-point scales. Higher scores indicate greater misinformation-detection self-efficacy.
Baseline (T0) and 2-week follow-up (T2).

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Critical and Electronic Health Literacy
Time Frame: Baseline (T0) and 2-week follow-up (T2).
Change from baseline in critical and electronic health literacy will be assessed using self-report items addressing participants' ability to find, evaluate, and apply online diet- and health-related information, including the ability to identify omissions, exaggeration, or weak evidence. Responses will be rated on 7-point scales. Higher scores indicate higher critical and electronic health literacy.
Baseline (T0) and 2-week follow-up (T2).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Beijing Normal University

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Xue Weng, Beijing Normal University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
September 1, 2026

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 30, 2026

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
June 30, 2027

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
August 31, 2026

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 31, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
September 3, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 3, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 31, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • Nutrition Misinformation Trial

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings